In previous studies, AIM2 has been shown to be upregulated in psoriatic skin lesions [21,40], and the blocking activation of the AIM2 inflammasome reduces inflammation and improves symptoms in animal models of psoriasis [62], suggesting that it may play a role in the chronic inflammation associated with the disease. This evidence concerns the gene AIM2 and psoriasis.